Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study.
Shan QiaoHuai-Kuan WuLing-Ling LiuMei-Ling WangRan-Ran ZhangTao HanXue-Wu LiuPublished in: Neuropsychiatric disease and treatment (2021)
The long-term outcome of patients with anti-LGI1 encephalitis was mostly favorable, although some patients continued to experience cognitive dysfunction. Early recognition is important for prompt initiation of immunotherapy that can improve clinical symptoms of anti-LGI1 encephalitis.